Trying Times for Biopharmaceuticals: How Researchers Can Flourish Amid Industry Challenges
2024 has not been kind to biopharmaceutical businesses. While turbulent times still lie ahead for many firms, new technologies and innovative solutions offer hope for navigating a way forward – if researchers can harness their potential effectively
